Nuvectis Pharma, Inc. Common Stock (NVCT) Stock Price

NVCTStock
$25.89+247.45%52W
Market Cap$845.15M
P/E
PEG Ratio
Div yield
Beta-0.24

NVCT Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)165.35%
Price vs S&P 500 (4W)17.38%
VGM Score96.59

NVCT Earnings Surprise History

Q2 25-0.30est. -0.25
Q3 25-0.44est. -0.25
Q4 25-0.31est. -0.31
Q1 26-0.26est. -0.31
Q2 26-0.30est. -0.26

NVCT Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
4.09
4.09
4.09
4.09

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
NVCTNuvectis Pharma, Inc. Common Stock
A$25.89
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Nuvectis Pharma, Inc. Common Stock

Nuvectis Pharma is a biopharmaceutical company focused on precision oncology. It develops novel, targeted small-molecule therapeutics for cancer patients with specific genetic profiles. The company's pipeline includes NXP800 and NXP900.